{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:08:07Z","timestamp":1773270487101,"version":"3.50.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jfma.2021.09.003","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:29:19Z","timestamp":1632270559000},"page":"736-748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Eye motor manifestations in children with neurometabolic disorders"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7974-2845","authenticated-orcid":false,"given":"Hsin-Pei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee-Chin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Jui","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Ching","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3692-1018","authenticated-orcid":false,"given":"Yen-Ju","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Tso","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib1","first-page":"179","article-title":"Inborn errors of metabolism overview: pathophysiology, manifestations, evaluation, and management","volume":"65","author":"Saudubray","year":"2018","journal-title":"Pediatr Clin"},{"issue":"11","key":"10.1016\/j.jfma.2021.09.003_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/adc.2005.091637","article-title":"The incidence of inherited metabolic disorders in the West Midlands, UK","volume":"91","author":"Sanderson","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jfma.2021.09.003_bib3","series-title":"Swaiman\u2019s pediatric neurology\u202f: principles and practice","author":"Swaiman","year":"2018"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ncl.2013.04.005","article-title":"Clinical neurogenetics: neurologic presentations of metabolic disorders","volume":"31","author":"Kwon","year":"2013","journal-title":"Neurol Clin"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.31887\/DCNS.2018.20.4\/jmsaudubray","article-title":"An overview of inborn errors of metabolism affecting the brain: from neurodevelopment to neurodegenerative disorders","volume":"20","author":"Saudubray","year":"2018","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.jfma.2021.09.003_bib6","series-title":"Neuroscience","year":"2001"},{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2014.284","article-title":"The cortex is in overall control of 'voluntary' eye movement","volume":"29","author":"Pouget","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.jfma.2021.09.003_bib8","series-title":"Handbook of clinical neurology","first-page":"379","article-title":"Chapter 14 - disorders of higher gaze control","author":"Kennard","year":"2011"},{"issue":"3","key":"10.1016\/j.jfma.2021.09.003_bib9","first-page":"953","article-title":"Role of the basal ganglia in the control of purposive saccadic","volume":"80","author":"Hikosaka","year":"2000","journal-title":"Eye Movements"},{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/eye.2014.271","article-title":"The cerebellum in eye movement control: nystagmus, coordinate frames and disconjugacy","volume":"29","author":"Patel","year":"2015","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/eye.2014.262","article-title":"A brief review of the clinical anatomy of the vestibular-ocular connections\u2014how much do we know?","volume":"29","author":"Bronstein","year":"2015","journal-title":"Eye"},{"issue":"12","key":"10.1016\/j.jfma.2021.09.003_bib12","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1468-1331.2009.02779.x","article-title":"Internuclear and supranuclear disorders of eye movements: clinical features and causes","volume":"16","author":"Karatas","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jfma.2021.09.003_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/B978-0-444-52903-9.00018-2","article-title":"Nuclear, internuclear, and supranuclear ocular motor disorders","volume":"102","author":"Pierrot-Deseilligny","year":"2011","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib14","first-page":"502","article-title":"Clinical studies of ocular motility disturbances. Part 1. Ocular motility disturbances: causes and incidence","volume":"40","author":"Kobashi","year":"1996","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1442-9071.1989.tb00484.x","article-title":"Supranuclear disorders of eye movement","volume":"17","author":"Milder","year":"1989","journal-title":"Aust N Z J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jfma.2021.09.003_bib16","first-page":"481","article-title":"Saccadic oscillations: membrane","volume":"7","author":"Shaikh","year":"2012","journal-title":"Int J Comput Model Algorithm Med"},{"issue":"S2","key":"10.1016\/j.jfma.2021.09.003_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00415-014-7385-9","article-title":"Central ocular motor disorders, including gaze palsy and nystagmus","volume":"261","author":"Strupp","year":"2014","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0953-4431(95)00105-C","article-title":"Internuclear ophthalmoplegia","volume":"7","author":"Young","year":"1995","journal-title":"Clin Eye Vis Care"},{"issue":"10","key":"10.1016\/j.jfma.2021.09.003_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0025-6196(12)61726-1","article-title":"Localization of lesions of the oculomotor nerve: recent concepts","volume":"66","author":"Brazis","year":"1991","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib20","first-page":"417","article-title":"Nuclear and infranuclear disorders","volume":"1","author":"Meienberg","year":"1992","journal-title":"Bailliere Clin Neurol"},{"issue":"10","key":"10.1016\/j.jfma.2021.09.003_bib21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.diii.2013.08.008","article-title":"Towards understanding ocular motility: III, IV and VI","volume":"94","author":"Koskas","year":"2013","journal-title":"Diagnostic and Interventional Imaging"},{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2005.03.024","article-title":"Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome)","volume":"140","author":"Egan","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib23","first-page":"12","article-title":"Ophthalmic findings in maple syrup urine disease","volume":"14","author":"Burke","year":"1991","journal-title":"Metab Pediatr Syst Ophthalmol (New York, NY : 1985)"},{"issue":"5","key":"10.1016\/j.jfma.2021.09.003_bib24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1203\/00006450-197305000-00003","article-title":"Hypoglycemia and maple syrup urine disease: defective gluconeogenesis","volume":"7","author":"Haymond","year":"1973","journal-title":"Pediatr Res"},{"issue":"8","key":"10.1016\/j.jfma.2021.09.003_bib25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2169\/internalmedicine.32.641","article-title":"Blindness due to non-ketotic hyperglycinemia: report of a 38-year-old, the oldest case to date","volume":"32","author":"Tanaka","year":"1993","journal-title":"Intern Med (Tokyo)"},{"issue":"12","key":"10.1016\/j.jfma.2021.09.003_bib26","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3349\/ymj.2019.60.12.1209","article-title":"Diagnostic challenges associated with GLUT1 deficiency: phenotypic variabilities and evolving clinical features","volume":"60","author":"Kim","year":"2019","journal-title":"Yonsei Med J"},{"issue":"S2","key":"10.1016\/j.jfma.2021.09.003_bib27","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.21037\/atm.2019.04.27","article-title":"Clinical presentations of Wilson disease","volume":"7","author":"Shribman","year":"2019","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12098-010-0234-7","article-title":"\u2018Eye-of-the-Tiger\u2019 sign and classic pantothenate kinase associated neurodegeneration","volume":"78","author":"Kamate","year":"2011","journal-title":"Indian J Pediatr"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archneur.55.4.554","article-title":"Pendular nystagmus in patients with peroxisomal assembly disorder","volume":"55","author":"Kori","year":"1998","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archopht.1966.00970050164004","article-title":"Ophthalmologic findings in Wilson's Hepatolenticular degeneration: with emphasis on ocular motility","volume":"75","author":"Goldberg","year":"1966","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archopht.1976.03910030265002","article-title":"Ophthalmoplegia and dissociated nystagmus in abetalipoproteinemia","volume":"94","author":"Yee","year":"1976","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02150148","article-title":"Nystagmus and subnormal electroretinographic response in non ketotic hyperglycinemia","volume":"225","author":"Hayasaka","year":"1987","journal-title":"Albrecht Von Graefe's Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/brain\/awt339","article-title":"Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency","volume":"137","author":"Euch-Fayache","year":"2013","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jimd.12024","article-title":"International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: diagnosis, treatment and follow up","volume":"42","author":"Altassan","year":"2019","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/aos.12897","article-title":"Genetic aetiology of ophthalmological manifestations in children - a focus on mitochondrial disease-related symptoms","volume":"94","author":"Widgren","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.52.2.366","article-title":"Short-chain acyl-CoA dehydrogenase deficiency: a cause of ophthalmoplegia and multicore myopathy","volume":"52","author":"Tein","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-3476(74)80568-8","article-title":"Ophthalmoplegia in maple syrup urine disease","volume":"84","author":"Zee","year":"1974","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.jfma.2021.09.003_bib38","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1212\/WNL.27.10.971","article-title":"Ophthalmoplegia as a sign of metabolic disease in the newborn","volume":"27","author":"MacDonald","year":"1977","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archopht.1953.00920030442003","article-title":"A type OF paralysis OF conjugate gaze (ocular motor apraxia)","volume":"50","author":"Cogan","year":"1953","journal-title":"AMA Archives of Ophthalmology"},{"issue":"3","key":"10.1016\/j.jfma.2021.09.003_bib40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0887-8994(00)00265-4","article-title":"Ocular motor dysfunction in Lesch-Nyhan disease","volume":"24","author":"Jinnah","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jfma.2021.09.003_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/TACG.S125962","article-title":"Maple syrup urine disease: mechanisms and management","volume":"10","author":"Blackburn","year":"2017","journal-title":"Appl Clin Genet"},{"issue":"5","key":"10.1016\/j.jfma.2021.09.003_bib42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5152\/dir.2017.16466","article-title":"MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases","volume":"23","author":"Cheng","year":"2017","journal-title":"Diagn Interv Radiol"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib43","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ana.24485","article-title":"Biochemical and molecular predictors for prognosis in non ketotic hyperglycinemia","volume":"78","author":"Swanson","year":"2015","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.jfma.2021.09.003_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2005.07.016","article-title":"Atypical variants of non ketotic hyperglycinemia","volume":"86","author":"Dinopoulos","year":"2005","journal-title":"Mol Genet Metabol"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mds.870060115","article-title":"Intermittent vertical supranuclear ophthalmoplegia and ataxia","volume":"6","author":"Nightingale","year":"1991","journal-title":"Mov Disord: Off J Move Disord Soc"},{"issue":"3","key":"10.1016\/j.jfma.2021.09.003_bib46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/jimd.12072","article-title":"Brain imaging in classic non ketotic hyperglycinemia: Quantitative analysis and relation to phenotype","volume":"42","author":"Stence","year":"2019","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic gaucher disease: demographic and clinical features of 131 patients enrolled in the International collaborative gaucher group neurological outcomes subregistry","volume":"33","author":"Tylki-Szyma\u0144ska","year":"2010","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.jfma.2021.09.003_bib48","first-page":"315","article-title":"Ophthalmic manifestations of Gaucher disease: the most common lysosomal storage disorder","volume":"103","author":"Winter","year":"2019"},{"issue":"12","key":"10.1016\/j.jfma.2021.09.003_bib49","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00234-018-2116-z","article-title":"Thalamic and dentate nucleus abnormalities in the brain of children with Gaucher disease","volume":"60","author":"Perucca","year":"2018","journal-title":"Neuroradiology"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jfma.2021.09.003_bib51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1749-6632.1996.tb18634.x","article-title":"Peroxisomal disorders: overview","volume":"804","author":"Moser","year":"1996","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.jfma.2021.09.003_bib52","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10072-016-2499-8","article-title":"Eye movement abnormalities in a patient with Zellweger spectrum disorder","volume":"37","author":"Rosini","year":"2016","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jfma.2021.09.003_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13023-015-0358-y","article-title":"Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment","volume":"10","author":"Serrano","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0002-9394(00)00569-9","article-title":"Ocular motor signs in an infant with carbohydrate-deficient glycoprotein syndrome type Ia","volume":"130","author":"Stark","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"15","key":"10.1016\/j.jfma.2021.09.003_bib55","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1212\/WNL.0b013e31826e2617","article-title":"Child Neurology: a case of PMM2-CDG (CDG 1a) presenting with unusual eye movements","volume":"79","author":"Coorg","year":"2012","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.jfma.2021.09.003_bib56","first-page":"1666","article-title":"Paroxysmal eye\u2013head movements in Glut1 deficiency syndrome","volume":"88","author":"Pearson","year":"2017"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib57","first-page":"458","article-title":"Imaging the metabolic footprint of Glut1 deficiency on the brain","volume":"52","author":"Pascual","year":"2002"},{"issue":"9","key":"10.1016\/j.jfma.2021.09.003_bib58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ejmg.2015.06.007","article-title":"From splitting GLUT1 deficiency syndromes to overlapping phenotypes","volume":"58","author":"Hully","year":"2015","journal-title":"Eur J Med Genet"},{"issue":"10","key":"10.1016\/j.jfma.2021.09.003_bib59","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3349\/ymj.2018.59.10.1190","article-title":"Ophthalmoplegia in mitochondrial disease","volume":"59","author":"Lee","year":"2018","journal-title":"Yonsei Med J"},{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib60","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.20550","article-title":"Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency","volume":"58","author":"Head","year":"2005","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jfma.2021.09.003_bib61","first-page":"366","article-title":"Short-chain acyl\u2013CoA dehydrogenase deficiency. A cause of ophthalmoplegia and multicore myopathy","volume":"52","author":"Tein","year":"1999"},{"issue":"3","key":"10.1016\/j.jfma.2021.09.003_bib62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0022-510X(77)90218-0","article-title":"Hypobetalipoproteinemia with abnormal prebetalipoprotein","volume":"31","author":"Kudo","year":"1977","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jfma.2021.09.003_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-3-19","article-title":"Abetalipoproteinemia: two case reports and literature review","volume":"3","author":"Zamel","year":"2008","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"10.1016\/j.jfma.2021.09.003_bib64","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/archopht.1981.03930020676010","article-title":"Ocular motor signs in some metabolic diseases","volume":"99","author":"Cogan","year":"1981","journal-title":"Arch Ophthalmol"},{"issue":"18","key":"10.1016\/j.jfma.2021.09.003_bib65","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.jfma.2021.09.003_bib66","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1113\/JP273670","article-title":"The role of dentate nuclei in human oculomotor control: insights from cerebrotendinous xanthomatosis","volume":"595","author":"Rosini","year":"2017","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-016-0419-x","article-title":"Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood","volume":"11","author":"Degos","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"10.1016\/j.jfma.2021.09.003_bib68","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/jnnp.2006.108415","article-title":"Ocular motility and Wilson\u2019s disease: a study on 34 patients","volume":"78","author":"Ingster-Moati","year":"2007","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"7 Supplement","key":"10.1016\/j.jfma.2021.09.003_bib69","article-title":"Saccadic eye-movement in Parkinsonism\/dystonia associated with hypermanganesemia due to mutation in SLC30A10 (P06.020)","volume":"vol. 80","author":"Pretegiani","year":"2013"},{"issue":"6","key":"10.1016\/j.jfma.2021.09.003_bib70","first-page":"1230","article-title":"Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations","volume":"27","author":"Hayflick","year":"2006","journal-title":"AJNR American journal of neuroradiology"},{"issue":"6","key":"10.1016\/j.jfma.2021.09.003_bib71","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jpeds.2012.12.069","article-title":"Bilateral external ophthalmoplegia in biotin-responsive basal ganglia disease","volume":"162","author":"Tabarki","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jfma.2021.09.003_bib72","series-title":"Biotin-responsive basal ganglia disease: neuroimaging features before and after treatment","author":"Kassem","year":"2014"},{"issue":"5","key":"10.1016\/j.jfma.2021.09.003_bib73","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejpn.2015.05.008","article-title":"Treatment of biotin-responsive basal ganglia disease: open comparative study between the combination of biotin plus thiamine versus thiamine alone","volume":"19","author":"Tabarki","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jfma.2021.09.003_bib74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-8-83","article-title":"Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases","volume":"8","author":"Alfadhel","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jfma.2021.09.003_bib75","doi-asserted-by":"crossref","first-page":"8342653","DOI":"10.1155\/2016\/8342653","article-title":"A case of ataxia with isolated vitamin E deficiency Initially diagnosed as Friedreich's ataxia","volume":"2016","author":"Bonello","year":"2016","journal-title":"Case Reports in Neurological Medicine"},{"issue":"3","key":"10.1016\/j.jfma.2021.09.003_bib76","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.64.3.368","article-title":"Ataxia with isolated vitamin E deficiency presenting as mutation negative Friedreich's ataxia","volume":"64","author":"Hammans","year":"1998","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"3","key":"10.1016\/j.jfma.2021.09.003_bib77","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00710425","article-title":"Familial isolated vitamin E deficiency. Extensive study of a large family with a 5-year therapeutic follow-up","volume":"18","author":"Amiel","year":"1995","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"10.1016\/j.jfma.2021.09.003_bib78","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jnnp.2008.155861","article-title":"Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients","volume":"80","author":"Trender-Gerhard","year":"2009","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.jfma.2021.09.003_bib79","series-title":"GeneReviews(\u00ae)","article-title":"GTP cyclohydrolase 1-deficient dopa-responsive dystonia","author":"Furukawa","year":"1993"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib80","first-page":"1","article-title":"Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5)","volume":"32","author":"Segawa","year":"2009","journal-title":"Chang Gung Med J"},{"issue":"7","key":"10.1016\/j.jfma.2021.09.003_bib81","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","article-title":"Dopa-responsive dystonia\u2014clinical and genetic heterogeneity","volume":"11","author":"Wijemanne","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jfma.2021.09.003_bib82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pediatrneurol.2019.02.008","article-title":"6-Pyruvoyltetrahydropterin synthase deficiency: review and report of 28 arab subjects","volume":"96","author":"Almannai","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.jfma.2021.09.003_bib83","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/brain\/awq087","article-title":"Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis","volume":"133","author":"Willemsen","year":"2010","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jfma.2021.09.003_bib84","first-page":"543","article-title":"Brain dopamine\u2013serotonin vesicular transport disease and its treatment","volume":"368","author":"Rilstone","year":"2013"},{"issue":"4","key":"10.1016\/j.jfma.2021.09.003_bib85","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/brain\/awu022","article-title":"Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood","volume":"137","author":"Ng","year":"2014","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jfma.2021.09.003_bib86","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13023-019-1244-9","article-title":"A comprehensive monocentric ophthalmic study with Gaucher disease type 3 patients: vitreoretinal lesions, retinal atrophy and characterization of abnormal saccades","volume":"14","author":"Hopf","year":"2019","journal-title":"Orphanet J Rare Dis"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621004253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621004253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:46:32Z","timestamp":1760539592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664621004253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0929664621004253"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.09.003","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eye motor manifestations in children with neurometabolic disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}